LK-903

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLK-903
Drug Alias NameLK-903
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A